Foley & Lardner LLP partner Louis Lehot is quoted in the Law360 article, “Attys Hopeful For Deals Pickup As JPMorgan Event Kicks Off,” offering perspective ahead of the annual J.P. Morgan Healthcare Conference in San Francisco on capital-raising and mergers and acquisitions, in particular for the health care and life sciences sector.
“What a life sciences investor needs is a risk-on environment and a good portfolio of companies that have molecules that can go to market in the near term,” explained Lehot. “And that means they can be an acquisition target.”
(Subscription required)
People
Related News
November 20, 2026
In the News
Louis Lehot Highlights Governance Challenges for Founder-Controlled Companies
Foley & Lardner LLP partner Louis Lehot authored the Law360 article, “Cloudflare Ruling Leaves Founder-Control Plans On Thin Ice,” examining the implications of the Delaware Court of Chancery’s recent Cloudflare ruling.
November 19, 2026
In the News
Susan Poll Klaessy Shares Her People-First Approach to Practice Leadership – 'Truly invest in people'
Foley & Lardner LLP partner Susan Poll Klaessy shares insights on leadership, client service, and developing talent in Law.com's “How I Made Practice Group Chair” series.
November 17, 2026
In the News
Brian Wheeler Comments on Private Equity Co-Investment Trends
Foley & Lardner LLP partner Brian Wheeler was featured in the PitchBook article “Middle-market funds are pulling in more LP money thanks to co-investments,” highlighting the growing role of co-investments in private equity fundraising and the opportunities they provide to limited partners (LPs).